| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,457 |
2,067 |
$120K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
474 |
410 |
$38K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
147 |
114 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
122 |
82 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
79 |
75 |
$6K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
73 |
55 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
171 |
145 |
$4K |
| 90670 |
|
49 |
27 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
56 |
50 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50 |
32 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
19 |
16 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
16 |
15 |
$1K |
| 87999 |
|
51 |
51 |
$918.00 |
| 96127 |
|
24 |
20 |
$350.40 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$192.96 |
| 90698 |
|
27 |
17 |
$172.80 |
| 1160F |
|
2,264 |
1,795 |
$43.73 |
| 1159F |
|
2,264 |
1,795 |
$43.54 |
| 3074F |
|
1,044 |
877 |
$0.00 |
| 1036F |
|
15 |
13 |
$0.00 |
| 3351F |
|
14 |
12 |
$0.00 |
| 3078F |
|
956 |
812 |
$0.00 |
| 99072 |
|
241 |
211 |
$0.00 |
| 1003F |
|
53 |
51 |
$0.00 |
| 3725F |
|
15 |
13 |
$0.00 |